Search Results for "covid-19"

ONS President-Elect Nancy Houlihan, RN, MA, AOCN^®, director of nursing and evidence-based practice at MSK Cancer Center in New York, NY, and Kathleen Shannon-Dorcy, RN, MN, PhD, director of clinical research, education, and practice at Seattle Cancer Care Alliance and staff scientist at the Fred Hutchinson Cancer Research Center in Seattle, WA, the first U.S. city and initial epicenter of confirmed COVID-19 cases, discuss their institutions’ response to the outbreak, lessons they’ve learned along the way, and best practices for other institutions to navigate patient care during the ongoing pandemic. 

ONS Chief Executive Officer Brenda Nevidjon, MSN, RN, FAAN, and members of the ONS Board of Directors from across the United States share a conversation with U.S. Representative Donna E. Shalala (D-FL) on Shalala’s role in the Institute of Medicine’s historic Future of Nursing report, how the COVID-19 coronavirus pandemic influenced global perspectives on nurses, and ways that nurses can advocate for improved healthcare policy reform.

Lisa Kennedy-Sheldon, PhD, APRN, AOCNP^®, FAAN, ONS’s chief clinical officer, joins Chris Pirschel, ONS staff writer/producer, to discuss the COVID-19 coronavirus and cancer, its impact on personal protective equipment availability, and ways nurses and patients can successfully navigate the complexities of the pandemic.

Lisa Richardson, MD, MPH, director of the Centers for Disease Control and Prevention’s (CDC’s) Division of Cancer Prevention and Control, joins Lisa Kennedy Sheldon, PhD, APRN, AOCNP^®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss CDC’s initiatives for cancer prevention and screening during the COVID-19 coronavirus and flu season. The conversation also covers how oncology nurses can help improve declining screening rates and access a new database of cancer incidence and biomarkers. The advertising messages in this episode are sponsored by Coherus BioSciences.

Lisa Kennedy-Sheldon, PhD, ANP-BC, AOCNP^®, FAAN, ONS clinical and scientific affairs liaison, joins Chelsea Backler, MSN, APRN, AGCNS-BC, AOCNS^®, ONS oncology clinical specialist and former home care nurse, to discuss how the COVID-19 coronavirus pandemic affects antineoplastics administration and safety considerations for in-home cancer care. More information is available in ONS’s recent position statement, linked in the episode notes.

This episode is supported by an educational grant from Genentech, a member of the Roche Group. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.

Norman “Ned” Sharpless, MD, director of the National Cancer Institute (NCI), joins Lisa Kennedy Sheldon, PhD, ANP-BC, AOCNP^®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss NCI’s COVID-19 coronavirus research efforts, how the agency is partnering with oncology nurses to understand the best care for patients with COVID-19 and cancer, nursing innovation during the pandemic, and the implications of delayed screening and care on future cancer incidence rates.  

ONS members Trey Woods, MSN, NP- C, faculty administrator and instructor of radiation oncology at the University of Mississippi Medical Center in Jackson; Bonnie Shaffer, DNP, RN, CNS, OCN®, clinical nurse specialist at St. Mary's Regional Hospital and Medical Center in Grand Junction, CO; and Marge Karas, MSN, RN, OCN®, CMSRN, staff nurse and nursing supervisor at the Wisconsin Emergency Assistance Volunteer Registry, join Anne Ireland, MSN, RN, AOCN®, CENP, director-at-large on the ONS board of directors, to discuss what they’ve learned and how they’re managing one year into the pandemic. The advertising messages in this episode are paid for by G1 Therapeutics, Inc.  

ONS member Donna Bydlon, BSN, RN, OCN^®, network director of infusion services at St. Luke's University Hospital and Health Network in Bethlehem, PA, and member of the Greater Lehigh Valley ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss nursing considerations for monoclonal antibodies to treat cancer and COVID-19 and how her institution responded to the pandemic. This episode is part of an ongoing series about outpatient oncology drug infusion. Other series' episodes are linked in the episode notes.

Tara A. Schwetz, PhD, acting director of the National Institute of Nursing Research (NINR) and associate deputy director of the National Institutes of Health (NIH), joins Lisa Kennedy Sheldon, PhD, APRN, AOCNP®, FAAN, ONS’s chief clinical officer, to discuss how nurse researchers are responding to the COVID-19 coronavirus and how NINR is looking to the future.

Richard Pazdur, MD, director of the U.S. Food and Drug Administration’s Oncology Center of Excellence (OCE), joins Lisa Kennedy Sheldon, PhD, APRN, AOCNP®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss oncology nurses’ contributions to cancer care, OCE’s initiatives, and the COVID-19 coronavirus pandemic’s implications for oncology drug approvals.